Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$15.34 USD
+0.19 (1.25%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $15.34 0.00 (0.00%) 6:56 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -2.02 |
EPS Last Quarter | -1.98 |
Last EPS Surprise | 33.11% |
ABR | 1.67 |
Earnings ESP
|
-8.42% |
---|---|
Current Year | -7.82 |
Next Year | -6.95 |
EPS (TTM) | -17.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.65M | 8.78M | 31.73M | 37.74M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 8.79M | 9.05M | 32.16M | 41.47M |
Low Estimate | 8.50M | 8.50M | 31.30M | 34.00M |
Year ago Sales | 0.00M | NA | 7.16M | 31.73M |
Year over Year Growth Est. | NA | NA | 342.97% | 18.93% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.02 | -2.12 | -7.82 | -6.95 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.85 | -1.91 | -7.41 | -6.63 |
High Estimate | -1.85 | -1.91 | -7.41 | -6.63 |
Low Estimate | -2.19 | -2.33 | -8.22 | -7.26 |
Year ago EPS | -3.24 | NA | -13.38 | -7.82 |
Year over Year Growth Est. | 37.65% | NA | 41.55% | 11.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.02 | -2.12 | -7.82 | -6.95 |
7 Days Ago | -1.85 | -1.91 | -7.41 | -6.63 |
30 Days Ago | -1.85 | -1.91 | -7.41 | -6.63 |
60 Days Ago | -3.29 | -3.66 | -12.65 | -13.45 |
90 Days Ago | -3.29 | -3.66 | -12.65 | -13.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.19 | -2.33 | -8.22 | -7.26 |
Zacks Consensus Estimate | -2.02 | -2.12 | -7.82 | -6.95 |
Earnings ESP | -8.42% | -9.91% | -5.18% | -4.54% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.98 | -1.66 | NA | -3.24 | NA |
Estimate | -2.96 | -2.74 | NA | -2.76 | NA |
Difference | 0.98 | 1.08 | NA | -0.48 | 0.53 |
Surprise | 33.11% | 39.42% | NA | -17.39% | 18.38% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more